Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis

Last updated: May 19, 2011
Sponsor: Ursapharm Arzneimittel GmbH
Overall Status: Completed

Phase

4

Condition

Blepharitis

Treatment

N/A

Clinical Study ID

NCT01357538
POFOBLE
S67-OPH-081
  • Ages > 18
  • All Genders

Study Summary

This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • written informed consent

  • ambulatory male and female patients 18 years of age or older

  • summarised score of signs and symptoms of blepharitis of 15 or more at baseline

Exclusion

Exclusion Criteria:

  • different ocular conditions

  • different system conditions

  • several concomitant medications

Study Design

Total Participants: 197
Study Start date:
February 01, 2009
Estimated Completion Date:
August 31, 2009

Study Description

Reduction of signs and symptoms of blepharitis

Connect with a study center

  • Kharkov District Clinical Hospital

    Kharkov,
    Ukraine

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.